Pacira BioSciences' Deferred Taxes rose 623.95% to $8.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.7 million, marking a year-over-year decrease of 42.11%. This contributed to the annual value of $20.6 million for FY2024, which is 32.06% up from last year.
Latest data reveals that Pacira BioSciences reported Deferred Taxes of $20.6 million as of FY2024, which was up 32.06% from $15.6 million recorded in FY2023.
In the past 5 years, Pacira BioSciences' Deferred Taxes ranged from a high of $20.6 million in FY2024 and a low of -$126.6 million during FY2020.
For the 3-year period, Pacira BioSciences' Deferred Taxes averaged around $9.4 million, with its median value being $15.6 million (2023).
In the last 5 years, Pacira BioSciences' Deferred Taxes crashed by 6,826.31% in 2020 and then skyrocketed by 296.54% in 2023.
Over the past 5 years, Pacira BioSciences' Deferred Taxes (MRY) stood at -$126.6 million in 2020, then soared by 108.59% to $10.9 million in 2021, then tumbled by 173.08% to -$7.9 million in 2022, then soared by 296.54% to $15.6 million in 2023, then soared by 32.06% to $20.6 million in 2024.
Its Deferred Taxes stands at $20.6 million for FY2024, versus $15.6 million for FY2023 and -$7.9 million for FY2022.

Peer Comparison

Historic Data

Download Data 🔒

Date	Value